Andrew Kay
Chairman presso NUCANA PLC
Patrimonio netto: - $ in data 31/03/2024
Profilo
Andrew Martin Kay is currently the Non-Executive Chairman at NuCana Plc and Ember Ltd.
He is also the Chairman at NeRRe Therapeutics Ltd., Blueberry Therapeutics Ltd., and Amulet Consulting Ltd.
Additionally, he serves as a Director at NeRRe Therapeutics Holdings Ltd.
and Chaperhome Ltd.
In the past, Mr. Kay held the position of President & Chief Executive Officer at Algeta ASA from 2009 to 2014.
He was also the Chairman at Wilson Therapeutics AB.
Prior to that, he served as the Executive Director-Commercial at Ultimate Finance Holdings Ltd.
and Renovo Ltd.
He was an Independent Director at KaNDy Therapeutics Ltd.
and held the role of Global Head-Marketing & Sales at Novartis UK Ltd.
from 1999 to 2003.
Mr. Kay completed his undergraduate degree at the School of Pharmacy.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
NUCANA PLC
-.--% | 31/12/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Posizioni attive di Andrew Kay
| Società | Posizione | Inizio |
|---|---|---|
| NUCANA PLC | Chairman | 21/12/2020 |
| Ember Ltd. | Chairman | - |
Blueberry Therapeutics Ltd.
 Blueberry Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Blueberry Therapeutics Ltd. engages in the development of innovative medicines. It offers nanomedicine, anti infection and anti microbial, anti inflammatory bowel diseases, acne, dermatitis and wound medicines. The company was founded by John Ridden and Mike Davies and is headquartered in Macclesfield, the United Kingdom. | Chairman | - |
| Amulet Consulting Ltd. | Chairman | - |
NeRRe Therapeutics Ltd.
 NeRRe Therapeutics Ltd. Medical DistributorsDistribution Services NeRRe Therapeutics Ltd. provides clinical and pre clinical drugs for treatment of neuronal hypersensitivity. It develops neurokinin receptor antagonists acquired from GlaxoSmithKline. The company was founded by Emiliangelo Ratti and Mike Trower in 2012 and is headquartered in Stevenage, the United Kingdom. | Chairman | 27/09/2017 |
NeRRe Therapeutics Holdings Ltd.
 NeRRe Therapeutics Holdings Ltd. Miscellaneous Commercial ServicesCommercial Services NeRRe Therapeutics Holdings Ltd. is a British biotechnology company founded in 2017. The private company is based in Stevenage, UK. The company is engaged in research and development of biotechnology. | Director/Board Member | 15/09/2017 |
Chaperhome Ltd.
 Chaperhome Ltd. Packaged SoftwareTechnology Services Chaperhome Ltd. is a British company that offers advanced safety features for enhanced personal security through their product, walksafe+ pro. The product provides additional functionalities and benefits to ensure the safety of its users. | Director/Board Member | 18/02/2021 |
Precedenti posizioni note di Andrew Kay
| Società | Posizione | Fine |
|---|---|---|
| ALGETA ASA | Chief Executive Officer | 14/03/2014 |
| INSPIRED CAPITAL PLC | Corporate Officer/Principal | 31/12/2008 |
| ░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░ ░░░░ | ░░░░░ ░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ | - |
Formazione di Andrew Kay
| School of Pharmacy | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| NUCANA PLC | Health Technology |
| Aziende private | 12 |
|---|---|
Ultimate Finance Holdings Ltd.
 Ultimate Finance Holdings Ltd. Finance/Rental/LeasingFinance Ultimate Finance Holdings Ltd. provides various SME lending products. The company was founded by Mark William James Ferguson and Sharon O'Kane in 1998 and is headquartered in Bradley Stoke, the United Kingdom. | Finance |
Renovo Ltd.
 Renovo Ltd. Pharmaceuticals: MajorHealth Technology Renovo Plc manufactures and distributes pharmaceutical products. The biopharmaceutical company develops novel pharmaceuticals products to prevent and reduce scarring in the skin, cardiovascular system, eye, central nervous system, internal adhesions, ligaments and systemic fibrotic disorders. The company was founded in 2000 and is headquartered in Manchester, United Kingdom. | Health Technology |
Novartis UK Ltd.
 Novartis UK Ltd. Pharmaceuticals: MajorHealth Technology Novartis UK Ltd. is an international pharmaceutical company. It strives to discover ways to improve and extend people’s lives. The company is headquartered in Frimley, the United Kingdom. | Health Technology |
NeRRe Therapeutics Ltd.
NeRRe Therapeutics Ltd. Medical DistributorsDistribution Services NeRRe Therapeutics Ltd. provides clinical and pre clinical drugs for treatment of neuronal hypersensitivity. It develops neurokinin receptor antagonists acquired from GlaxoSmithKline. The company was founded by Emiliangelo Ratti and Mike Trower in 2012 and is headquartered in Stevenage, the United Kingdom. | Distribution Services |
Wilson Therapeutics AB
 Wilson Therapeutics AB Pharmaceuticals: MajorHealth Technology Wilson Therapeutics AB engages in the development of novel therapies for patients with rare copper-mediated disorders. The company was founded on April 25, 2012 and is headquartered in Stockholm, Sweden. | Health Technology |
Blueberry Therapeutics Ltd.
Blueberry Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Blueberry Therapeutics Ltd. engages in the development of innovative medicines. It offers nanomedicine, anti infection and anti microbial, anti inflammatory bowel diseases, acne, dermatitis and wound medicines. The company was founded by John Ridden and Mike Davies and is headquartered in Macclesfield, the United Kingdom. | Health Technology |
| Amulet Consulting Ltd. | |
KaNDy Therapeutics Ltd.
 KaNDy Therapeutics Ltd. BiotechnologyHealth Technology KaNDy Therapeutics Ltd. engages in the provision of a treatment of chronic debilitating female sex-hormone related conditions. Its product is NT-814 a non-hormonal therapy to treat moderate to severe post-menopausal vasomotor symptoms. The company was founded by Dr. Mike Trower and Mary Kerr in 2017 and is headquartered in Stevenage, the United Kingdom. | Health Technology |
NeRRe Therapeutics Holdings Ltd.
NeRRe Therapeutics Holdings Ltd. Miscellaneous Commercial ServicesCommercial Services NeRRe Therapeutics Holdings Ltd. is a British biotechnology company founded in 2017. The private company is based in Stevenage, UK. The company is engaged in research and development of biotechnology. | Commercial Services |
Chaperhome Ltd.
Chaperhome Ltd. Packaged SoftwareTechnology Services Chaperhome Ltd. is a British company that offers advanced safety features for enhanced personal security through their product, walksafe+ pro. The product provides additional functionalities and benefits to ensure the safety of its users. | Technology Services |
Algeta ASA
 Algeta ASA Pharmaceuticals: MajorHealth Technology Algeta ASA is engaged in the development of products for the treatment of cancer. The company focuses on the development of anti-cancer drugs, and its research and development of compounds focuses on the various applications of a few base compounds. Its products, Alpharadin and Thorium-227, are being developed for treatment of skeletal metastases originating from prostate and breast cancer. The company was founded by Roy H. Larsen and Øyvind Sverre Bruland in 1997 and is headquartered in Oslo, Norway. | Health Technology |
| Ember Ltd. |
- Borsa valori
- Insiders
- Andrew Kay
